Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 11
2003 13
2004 10
2005 11
2006 7
2007 8
2008 8
2009 10
2010 7
2011 6
2012 10
2013 15
2014 9
2015 13
2016 17
2017 17
2018 17
2019 10
2020 11
2021 26
2022 16
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

231 results
Results by year
Filters applied: . Clear all
Page 1
Immune checkpoint blockade in HIV.
Gubser C, Chiu C, Lewin SR, Rasmussen TA. Gubser C, et al. Among authors: rasmussen ta. EBioMedicine. 2022 Feb;76:103840. doi: 10.1016/j.ebiom.2022.103840. Epub 2022 Feb 2. EBioMedicine. 2022. PMID: 35123267 Free PMC article. Review.
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.
Uldrick TS, Adams SV, Fromentin R, Roche M, Fling SP, Gonçalves PH, Lurain K, Ramaswami R, Wang CJ, Gorelick RJ, Welker JL, O'Donoghue L, Choudhary H, Lifson JD, Rasmussen TA, Rhodes A, Tumpach C, Yarchoan R, Maldarelli F, Cheever MA, Sékaly R, Chomont N, Deeks SG, Lewin SR. Uldrick TS, et al. Among authors: rasmussen ta. Sci Transl Med. 2022 Jan 26;14(629):eabl3836. doi: 10.1126/scitranslmed.abl3836. Epub 2022 Jan 26. Sci Transl Med. 2022. PMID: 35080914 Free PMC article.
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.
Rasmussen TA, Rajdev L, Rhodes A, Dantanarayana A, Tennakoon S, Chea S, Spelman T, Lensing S, Rutishauser R, Bakkour S, Busch M, Siliciano JD, Siliciano RF, Einstein MH, Dittmer DP, Chiao E, Deeks SG, Durand C, Lewin SR. Rasmussen TA, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1973-e1981. doi: 10.1093/cid/ciaa1530. Clin Infect Dis. 2021. PMID: 33677480 Free PMC article. Clinical Trial.
Clinical Interventions in HIV Cure Research.
Rasmussen TA, Søgaard OS. Rasmussen TA, et al. Adv Exp Med Biol. 2018;1075:285-318. doi: 10.1007/978-981-13-0484-2_12. Adv Exp Med Biol. 2018. PMID: 30030798 Review.
Cancer therapies in HIV cure research.
Rasmussen TA, Anderson JL, Wightman F, Lewin SR. Rasmussen TA, et al. Curr Opin HIV AIDS. 2017 Jan;12(1):96-104. doi: 10.1097/COH.0000000000000328. Curr Opin HIV AIDS. 2017. PMID: 27607592 Free PMC article. Review.
Reversal of Latency as Part of a Cure for HIV-1.
Rasmussen TA, Tolstrup M, Søgaard OS. Rasmussen TA, et al. Trends Microbiol. 2016 Feb;24(2):90-97. doi: 10.1016/j.tim.2015.11.003. Epub 2015 Dec 11. Trends Microbiol. 2016. PMID: 26690612 Review.
Quorum-sensing inhibitors as anti-pathogenic drugs.
Rasmussen TB, Givskov M. Rasmussen TB, et al. Int J Med Microbiol. 2006 Apr;296(2-3):149-61. doi: 10.1016/j.ijmm.2006.02.005. Epub 2006 Feb 28. Int J Med Microbiol. 2006. PMID: 16503194 Review.
231 results